Intramyocardial Inflammation Predicts Adverse Outcome in Patients With Cardiac AL Amyloidosis

European Journal of Heart Failure- United States

doi 10.1002/ejhf.1039

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Cardiac Involvement Is Underdiagnosed in Patients With Biopsy-Proven Systemic AL Amyloidosis

International Cardiovascular Forum Journal
2016English

Cardiac Amyloid Burden Assessment by T1 Mapping Predicts Survival in Patients With Systemic AL Amyloidosis - A 2 Year Follow-Up Study

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2014English

Intramyocardial Hemorrhage Assessed by T2* Imaging Is Associated With Myocardial Damage and May Predicts Long-Term Outcome in Patients With Acs

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Cardiac Biomarkers and Health-Related Quality of Life in Patients With Light Chain (AL) Amyloidosis

British Journal of Haematology
Hematology
2018English

Inflammation in Cardiac Amyloidosis: Prognostic Marker or Therapeutic Target?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Cardiac and Multi-Organ Transplantation in Patients With Amyloidosis

2011English

Long-Term Successful Outcome of Sequential Cardiac and Allogeneic Bone Marrow Transplantations in Severe AL Amyloidosis

Bone Marrow Transplantation
TransplantationHematology
2005English

Impaired Thrombolytic Status Predicts Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention

Thrombosis and Haemostasis
Hematology
2017English

Diagnostic Utility of Troponin-I in Patients With Cardiac Amyloidosis

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy